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Abstract
Gangliosides, a member of the glycosphingolipid family, are heterogeneously expressed in biological membranes and are
particularly enriched within the central nervous system. Gangliosides consist of mono- or poly-sialylated oligosaccharide
chains of variable lengths attached to a ceramide unit and are found to be intimately involved in brain disease
development. The purpose of this study is to examine the spatial profile of ganglioside species using matrix-assisted laser
desorption/ionization (MALDI) imaging (IMS) following middle cerebral artery occlusion (MCAO) reperfusion injury in the
mouse. IMS is a powerful method to not only discriminate gangliosides by their oligosaccharide components, but also by
their carbon length within their sphingosine base. Mice were subjected to a 30 min unilateral MCAO followed by long-
term survival (up to 28 days of reperfusion). Brain sections were sprayed with the matrix 5-Chloro-2-mercaptobenzothia-
zole, scanned and analyzed for a series of ganglioside molecules using an Applied Biosystems 4800 MALDI TOF/TOF.
Traditional histological and immunofluorescence techniques were performed to assess brain tissue damage and
verification of the expression of gangliosides of interest. Results revealed a unique anatomical profile of GM1, GD1 and
GT1b (d18:1, d20:1 as well as other members of the glycosphingolipid family). There was marked variability in the ratio of
expression between ipsilateral and contralateral cortices for the various detected ganglioside species following MCAO-
reperfusion injury. Most interestingly, MCAO resulted in the transient induction of both GM2 and GM3 signals within the
ipsilateral hemisphere; at the border of the infarcted tissue. Taken together, the data suggest that brain region specific
expression of gangliosides, particularly with respect to hydrocarbon length, may play a role in neuronal responses to
injury.
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Introduction
Gangliosides are a member of the glycosphingolipid family and
consist of mono- to poly-sialylated oligosaccharide chains attached
to a ceramide base. Gangliosides are amphiphilic molecules found
within the outer layer of the plasma membrane of all vertebrate
cells [1] but are particularly enriched within the plasma mem-
brane of the central nervous system and account for 1% of the total
lipid weight within the brain [2,3]. The main gangliosides within
the adult human brain are GM1, GD1a, GD1b and GT1b [4].
Gangliosides, specifically GM1, have been identified as a major
lipid constituent of membrane rafts in many cell types [5,6].
Gangliosides have a wide range of CNS functions including
membrane function [7], axon stability and regeneration [8],
differentiation [9] and neurodegeneration [10–12]. The ceramide
moieties of gangliosides are also heterogeneous with respect to
carbon chain length within their sphingosine base. It has been
suggested that d18:1 and d20:1 gangliosides are differentially re-
gulated and may possess unique roles with respect to neuronal
function and cell death [13,14].
Altered ganglioside synthesis and its role in neurodegeneration
have garnered recent attention. Studies have shown that mice
deficient in glycosyltransferases, enzymes that are responsible for
the synthesis of gangliosides, exhibited degeneration within both
the PNS and CNS. Accumulations of GM2 and GM3, precursors
to GM1, can occur in the absence of proper ganglioside synthesis.
High levels of GM2 and GM3 have been implicated in lysosomal
disorders and lead to neurodegeneration [11,15,16].
Imaging mass spectrometry (IMS) using matrix-assisted laser
desorption/ionization (MALDI-TOF) is a powerful tool for
visualizing the spatial distribution of various molecules in situ
[17]. IMS has been used to examine the spatial profiling of lyso-
phosphatidylcholine following stroke in the rat [18]. IMS has also
been used successfully to examine the spatial profile of gangliosides
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and other glycosphingolipids in the mouse brain during develop-
ment [13,14]. The objective of this study was to examine the
temporal and spatial profile of ganglioside species using IMS
following middle cerebral artery occlusion (MCAO) and long-term
reperfusion injury in the mouse. This is a potent method to not
only discriminate gangliosides by their oligosaccharide compo-
nents, but also by their hydrocarbon lengths. Here we describe a
unique anatomical profile of GM1, GD1 and GT1b (d18:1, d20:1)
as well as other members of the glycosphingolipid family. There
was marked variability in the ratio of expression between ipsilat-
eral and contralateral cortices for the various detected ganglioside
species following MCAO-reperfusion injury. Interestingly, MCAO
resulted in the transient induction of both GM2 and GM3 signals
within the ipsilateral hemisphere, at the border of the infarcted
tissue. Immunofluorescently labeled brain tissue sections with
antibodies against GM1, GD1a and GM3 revealed similar ex-
pression profiles to those observed using IMS. Taken together, the
data suggest that brain region specific regulation of gangliosides,
particularly with respect to sphingosine base length, may play a
role in neuronal responses to injury.
Results
Imaging MALDI-TOF detection of gangliosides within the
mouse brain
Adjacently sectioned coronal mouse brain sections were stained
with Cresyl Violet to determine the neuroanatomical regions to be
selected for regions of interest (ROIs). ROIs included the cerebral
cortex, striatum and hippocampus (Figure 1A). Mass spectrum
from each ROI was extracted and plotted (Figure 1B). In negative
ion mode sulfatides (1000–1200), GM1 (1545, 1573), GD1
(comprising both GD1a and GD1b species which cannot be
distinguished by MALDI-TOF; 1800–1900), and GT1b (2150–
2250) were detected. For GM1, both the d18:1 and d20:1 moieties
were detected (Figure 1 C,D). For GD1 and GT1b d18:1 and
d20:1 species were also detected along with their sodium (GD1
d18:1 Na+ - 1860; GD1 d20:1 Na+ - 1888, GT1b d18:1 Na+ -
2151, GT1b d20:1 Na+ - 2179) and potassium (GD1 d18:1 K+ -
1876; GD1 d20:1 K+ - 1904, GT1b d18:1 K+ - 2167, GT1b d20:1
K+ - 2195) adducts. No sodium or potassium adducts were
detected with GM1 species. The sodium and potassium adducts
Figure 1. Imaging of gangliosides within a mouse brain using MALDI-TOF. (A): Sham-operated mice were sacrificed and their brains were
removed, flash frozen and sectioned on a freezing cryostat. ROIs were determined from adjacent 10 mm thick mouse brain sections stained with
Cresyl violet. (B): Total ion chromatograph depicting the mass spectra from the highlighted ROIs. Peaks were identified corresponding to GM4/
sulfatides, GM1, GD1 (a and b) and GT1b. (C): IMS of a coronal mouse brain section corresponding to GM1 d18:1 (m/z 1546); and GM1 d20:1 (m/z
1574) (D). Note the unique neuroanatomical profiles, specifically within the hippocampus for each species. Colored bars in C and D represent relative
levels of MALDI-TOF signal.
doi:10.1371/journal.pone.0020808.g001
MALDI Imaging of Gangliosides following Stroke
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for GD1 and GT1b but not GM1 were in confirmation with
previous studies [13,14].
Detection and quantification of GM1 following MCAO
and long-term reperfusion in the mouse
Both GM1 d18:1 and d20:1 species were detected in multiple
brain regions (Figure 2) including the cerebral cortex, hippocam-
pus and striatum. Sham-operated mice demonstrated high levels
of GM1 d18:1 throughout the brain; whereas d20:1, although
detectable in small amounts throughout the brain, was mainly
detected within the dentate gyrus of the hippocampus. The
expression of GM1 d18:1 and GM1 d20:1 differed following
MCAO and long-term reperfusion. At 24 h and 3 d post-MCAO,
GM1 d18:1 signal was up-regulated within the ipsilateral cortex,
striatum and hippocampus and the level of GM1 d18:1 peaked by
7 d post-MCAO. By 14 d, the signal had dropped within the
ipsilateral hemisphere within brain areas where tissue viability had
been lost. GM1 d20:1 was up-regulated at 24 h and peaked by 3 d
post-MCAO within the ipsilateral cortex and in the hippocampi of
both sides of the hemisphere. By 7 d post-MCAO, GM1 d20:1
was restricted to regions surrounding the infarct core, as de-
termined by Cresyl violet staining. It is important to note that in
each time point, the imaging depicts relative signal between ipsi-
lateral and contralateral hemispheres. For example, even though
little signal is visually shown in the contralateral hemisphere of 3 d
and 7 d post-MCAO, a concrete mass spectrum can still be
derived.
To quantify the relative changes in GM1 d18:1 and d20:1
between the ipsilateral and contralateral sides of the brain, ROIs
were chosen based on Cresyl violet staining of adjacent brain
sections and confirmed using a mouse brain atlas [19]. These
regions included two measurements in the infarcted cerebral
cortex, a region containing the ventral secondary auditory cortex,
somatosensory S1 and S2 cortices and granular insular cortex
(cortex I); the area adjacent comprising primary motor, somato-
sensory trunk region and dysgranular region (Cortex II), as well as
the hippocampus and striatum (Figure 3a). ROI measurements
were also made in corresponding neuroanatomical regions of the
contralateral hemisphere. The mass spectra were extracted from
each ROI and plotted as shown in Figure 3B. Two distinct peaks
corresponding to GM1 d18:1 (m/z 1545) and GM1 d20:1 (m/z
1573) were easily detected in each ROI. The MALDI signal from
each ROI was quantified by integrating the area under each peak
and calculating the fold change of intensity of ipsilateral ROI
signal to contralateral ROI signal from the corresponding neu-
roanatomical region. The fold change of ipsilateral to contralateral
ROIs following MCAO was plotted for each reperfusion time
point for both GM1 d18:1 (Figure 3C) and d20:1 (Figure 3D).
GM1 increases within the ipsilateral cortex I at 24 h following
MCAO and then falls below contralateral levels by 14 d post-
MCAO (Figure 3C). GM1 d18:1 signal within the ipsilateral
Cortex II peaked by 3 d whereas it peaked by 7 d within the
ipsilateral hippocampus. GM1 d18:1 also increased within the
ipsilateral striatum at 24 h, 3 d and 7 d post-MCAO. GM1 d20:1
level increased most dramatically within the ipsilateral Cortex II
region and modestly increased within the ipsilateral hippocampus
and striatum by 3 d post-MCAO (Figure 3D).
Imaging GD1 and GT1b following MCAO reperfusion
injury
In order of magnitude, the detected level of relative expression
within the non-injured mouse brain was GM1 followed by GD1
and GT1b. All three species demonstrated a similar neuroana-
tomical expression profile during MCAO-reperfusion. Following
MCAO, both GD1 d18:1 and d20:1 increased within the ipsi-
lateral cortex (cortex I and II), hippocampus and striatum at 24 h
and remained elevated within the cortex II region, hippocampus
and striatum through 7 d (Figure 4). By 14 d the level of GD1 was
equal within the hippocampus and decreased within the non-
viable cortical tissue.
The level of GT1b was detectable within the mouse brain albeit
at a low level compared to that of GM1 and GD1 (Figure 4).
Following MCAO, both GT1 d18:1 and d20:1 increased within
the ipsilateral cortex, hippocampus and striatum at 24 h and
remained elevated within the Cortex II region, hippocampus and
striatum through 7 d. By 14 d the levels of GT1 were equal within
the hippocampus while GT1 decreased within the non-viable
cortical tissue.
Figure 2. GM1 imaging within a mouse brain following a unilateral MCAO and long-term survival. Mice received a 30 min unilateral
MCAO followed by reperfusion time points of 24 h, 3 d, 7 d, 14 d and 28 d. Adjacent sections were either stained with Cresyl violet; or were scanned
using mass spectrometry imaging. Mass spectrometry images for each time point were from the same coronal tissue section. Both GM1 d18:1 (m/z
1546) and d20:1 (m/z 1574) were expressed at higher levels within the MCAO-induced infarcted hemisphere, specifically within the cerebral cortex,
hippocampus and striatum.
doi:10.1371/journal.pone.0020808.g002
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Detection of GM2 and GM3 within the ipsilateral
hemisphere following MCAO
Neither GM2 nor GM3 were detected within the brains of
uninjured sham-operated mice (Figure 5). Following 3 d post-
MCAO, GM2 was up-regulated within the ipsilateral cortex and
hippocampus (Figure 5). GM2 remained elevated within these
brain regions and spread to the ipsilateral striatum by 7 d post
MCAO. There was very little GM2 signal within the mouse brain
by 14 d and was completely absent by 28 d post-MCAO. GM3
signal demonstrated a temporal and neuroanatomical profile
similar to that of GM2, with the exception that GM3 d18:1 was
detected in both the contralateral and ipsilateral hippocampi at 3
and 7 d post-MCAO whereas GM3 d20:1 was detected in both
the contralateral and ipsilateral hippocampi at 3 d post-MCAO
only (Figure 5). The greatest intensity of GM2 and GM3 signal
appeared to be at the border of the infarcted tissue based on Cresyl
violet staining.
To confirm some of the ganglioside expression profiles detected
with IMS, GM1, GD1a and GM3 expression were detected by
indirect immunofluorescence staining and visualized under a
confocal microscope (Figure 6). In the uninjured mouse brain,
GM1 was mostly restricted to white matter fiber tracts, whereas
GD1a appeared within the grey matter, both of which were
confirmed in previous reports [20,21]. GM3 was not detected by
immunofluorescence in any brain region of the uninjured brain,
confirming MALDI-TOF data. Both GM1 and GD1a expression
increased within the ipsilateral MCAO-damaged cortex at 7 d
post-MCAO, and both of which matched the temporal profiles
detected by IMS. GM3 expression was dramatically increased
within the ipsilateral MCAO-induced cortical tissue; as well as 7 d
post-MCAO and appeared to be restricted mostly to gray matter
regions. Although the antibodies cannot detect the difference
between d18:1 and d20:1 moiety, it appears that the temporal
expression profile of gangliosides detected by MALDI-TOF and
immunofluorescence are fairly similar.
Summary of Ganglioside expression following MCAO
reperfusion injury
The fold increases and decreases from ipsilateral to contralateral
ROIs were determined for GM1, GD1, GT1b, GM2 and GM3
for both d18:1 and d20:1 species following MCAO and various
reperfusion time points - sham, 24 h, 3 d, 7 d, 14 d and 28 d.
Figure 3. Quantifying GM1 species within the mouse brain following MCAO and long-term survival. (A): IMS of GM1 d18:1 from a mouse
receiving a MCAO followed by 7 d reperfusion. ROIs were highlighted as shown. (B): Mass spectra were extracted from ipsilateral and contralateral
ROIs. (C,D): The area underneath the total ion chromatograph curve was calculated and plotted. Data represents the mean ratio of signal intensity
between ipsilateral and contralateral ROIs; * indicates p,0.05, n = 3.
doi:10.1371/journal.pone.0020808.g003
MALDI Imaging of Gangliosides following Stroke
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Figure 4. IMS of GD1 (K+) d18:1 (m/z 1876) and d20:1 (m/z 1904), GT1b (K+) d18:1 (m/z 2167) and d20:1 (m/z 2195) following MCAO-
reperfusion. Both GD1 and GT1 were expressed at higher levels within the MCAO-induced infarcted hemisphere, specifically within the cerebral
cortex, hippocampus and striatum.
doi:10.1371/journal.pone.0020808.g004
Figure 5. IMS of GM2 d18:1 (m/z 1384), GM2 d20:1 (m/z 1412), GM3 d18:1 (m/z 1181) and GM3 d20:1 (m/z 1209) following MCAO-
reperfusion. Neither GM2 nor GM3 were detected in sham-operated mice or mice receiving MCAO followed by 24 h reperfusion. GM2 and GM3
(d18:1 and d20:1) were detected within the cortex, at the periphery of the injured tissue, as well as within the hippocampus, striatum and thalamic
structures at 3 and 7 d. Neither GM2, nor GM3 (d18:1 or d20:1), were detected in mice by 28 d after MCAO.
doi:10.1371/journal.pone.0020808.g005
MALDI Imaging of Gangliosides following Stroke
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(Figure 7). All four anatomical ROIs (cortex I, cortex II, hippo-
campus and striatum) demonstrated unique ganglioside profiles
with respect to oligosaccharide structure as well as sphingosine
(d18:1 vs. d20:1) chain length. Generally, the degree of change
in d18:1 and d20:1 species was relatively similar with a few
exceptions. The d20:1 moiety of GM1, GD1 and GT1b increased
at a greater rate within the Cortex II region. Conversely the d18:1
moiety of GM2 and GM3 increased at a greater rate within the
hippocampus and striatum. Also, in most cases, the greatest level
of ganglioside change occurred at the 3 and 7 d time points, which
were time points associated with secondary neuronal death and
neuroinflammation in response to the MCAO.
Discussion
Gangliosides have been shown to possess a wide variety of
functions within the CNS [7–11]; however, their expression in the
brain following cerebral ischemia and reperfusion has not been well
studied. Here, we demonstrate, for the first time, the spatial and
temporal profile of gangliosides following MCAO and long-term
survival in a mouse model of stroke. The advantage of looking over
extended reperfusion time periods is that one can identify several
clinically relevant pathological events that follow a stroke. Some of
these events include the formation of the necrotic core, delayed
neuronal death, scar formation and tissue remodeling.
The transient induction of GM2 and GM3 from 3 to 7 d
following MCAO was an intriguing finding. First, neither GM2
nor GM3 could be detected within the uninjured sham brain. The
lack of detection does not suggest that no GM2 and GM3 exist
within the mouse brain, but does suggest that they were clearly
below our level of detection which is consistent with previous studies
[4,14]. The expression of GM2 and GM3 appeared to demonstrate
a crescent-like distribution at the border of the infarcted tissue
region and extended into regions within the hippocampus and
thalamus. Previous reports have demonstrated that accumulations
of GM2 and GM3, precursors to GM1, can occur in the absence of
proper ganglioside synthesis and that sustained levels of GM2 and
GM3 have been implicated in lysosomal disorders and lead to
neurodegeneration [11,15,16]. Our data may be congruent with
this possibility given that GM2 and GM3 expression were seen at
the border of the infarcted tissue.
Data obtained using MALDI-MS imaging of gangliosides does
have its limitations. Data analysis should be interpreted with
caution as studies have demonstrated that sialic acid is susceptible
to loss during the MALDI-MS process [14,22–24]. Although we
were able to detect GD1 and GT1b species, a significant portion of
these species were likely degraded and thus detected as GM1
during the scan. This has been previously addressed in a study
examining MS on authentic samples of GM1, GD1 and GT1
gangliosides. Data from this study demonstrated ion signals at m/z
1544 and 1572 that corresponded to ions originating from GM1
and GD1, but not GT1. Ions at m/z 1874 and 1902 (GD1)
contained barely traceable levels of GT1-derived signals [14].
One of the distinct advantages of using IMS technology to
examine gangliosides is the ability to differentiate species based on
their carbon chain length within the sphingosine base. Antibodies
specific to the oligosaccharide moiety of gangliosides may be used
to visualize individual gangliosides with different oligosaccharide
units. However, antibodies cannot detect whether or not these
gangliosides have 18 or 20 carbons on their sphingosine base. In
any case, there was concurrence for the data obtained by IMS and
immunofluorescence.
Figure 6. Detection of GM1, GD1a and GM3 by immunofluorescence staining within the mouse brain following MCAO. Mice were
perfusion fixed with 4% formaldehyde. Coronal brain sections at 10 mm thickness were cut and immunostained with either mouse anti-GM1, GD1a or
GM3 (red color). Sections were counterstained with 2 mg/ml Hoechst 33258 (blue color) and imaged with an Olympus Fluoview FV1000 confocal laser
scanning microscope. Photomicrographs depict the border area between ischemic infarct core and the peri-infarct area clearly separated by the
white colored line. At 7 d reperfusion, the border of the stroke-induced infarct is visible (lower left half). Expression levels of GM1, GD1a and GM3
increased within the infarcted ipsilateral cortex. GM1 and GM3 increases were restricted to the stroke-induced infarct core (abbreviations: ctx, cerebral
cortex; cc – corpus callosum; isc, ischemic area).
doi:10.1371/journal.pone.0020808.g006
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Previous studies have suggested that lipids can change their
behaviour within a cell depending on their fatty acid chain length
[25]. Our studies demonstrate discrete neuroanatomical locations
for gangliosides based on their carbon chain length. For example,
within the hippocampus, the d18:1 moiety of GM1, GD1 and
GT1b appears to be expressed within the oriens layer, stratum
radiatum and molecular layers; whereas the d20:1 moiety is
mainly restricted to the dentate gyrus. The findings are consistent
with previous studies [13,14] and provide a potential intriguing
role for d20:1 gangliosides in mediating functions of the subgra-
nular zone within the dentate gyrus; a region where adult hippo-
campal neurogenesis occurs.
In this study, the change of d18:1 and d20:1 moieties were
unique, especially within the cortex II ROI, a region that was
based on Cresyl violet staining and depicts cortical tissue that was
typically near the border of the infarct. In the case of GM1, GD1
and GT1b, although there was no tissue viability as assessed by the
Cresyl violet staining, there was a strong signal of d20:1 within the
Cortex II ROI. In fact, the quantification data clearly demon-
strated a strong induction of d20:1 relative to d18:1 for these
gangliosides within the cortex II ROI (Figure 7). This finding
suggests that different metabolic events are still occurring within
the ‘infarcted tissue’. Moreover, given that the location of GM1
d20:1 expression was located at the border of the infarcted tissue; it
may suggest a potential role for the d20:1 moiety in either infarct
expansion or ‘sealing’ the region from further expansion. Con-
versely, the opposite trend was observed within the cortex II ROI
for GM2 and GM3, whereby the d18:1 moiety was induced at a
greater level compared to d20:1.
Combining the sensitivity of IMS with the superior anatomi-
cal resolution of immunofluorescence proved to be a valuable
approach to examining the temporal profile of ganglioside ex-
pression following MCAO and long-term recovery. Our data
demonstrate the expression of GM1 within the white matter fiber
tracts and GD1a within the gray matter and are consistent with
previous studies describing neuronal expression profiles of
gangliosides [20,21,26–28]. The novel finding of GM2 by IMS
and GM3 by both IMS and immunofluorescence may suggest the
expression occurred within gray matter. This finding needs to be
further explored with specificity, especially with respect to cell type
expression patterns. One study has indicated a role for GM3
signaling within astrocytes [27], and thus it is possible that given
GM3 expression timing following MCAO (3 and 7 d post-
MCAO), GM3 may play an important role in neuroinflammatory
mechanisms following stroke. In summary, the data suggest that
brain region specific regulation of gangliosides, particularly with
Figure 7. Summary of ganglioside expression with respect to ROIs. The mean intensities of ganglioside derived from the mass spectra were
expressed as fold increases/decreases between ipsilateral and contralateral ROIs. Each paired bar represents the d18:1 (black-colored bar) and d20:1
(red-colored bar) moieties for each ganglioside species detected. Bars within the box represent the time course (sham, 24 h, 3 d, 7 d, 14 d and 28 d)
following MCAO for each ganglioside (GM3, GM3, GM1, GD1 and GT1b).
doi:10.1371/journal.pone.0020808.g007
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respect to sphingosine base length, may play a role in brain injury
response to cerebral ischemia.
Materials and Methods
Animals
All procedures using animals were approved by the Institute for
Biological Sciences Animal Care Committee (protocol 2007.13)
following the guidelines established by the Canadian Council
on Animal Care. C57BL/6 mice (20–23 g) were obtained from
Charles River (St Foie, PQ, Canada).
Unilateral Middle Cerebral Artery Occlusion (MCAO) and
Reperfusion in mouse
Under temporary isofluorane anesthesia, mice were subjected to
30 min MCAO using an intraluminal filament as previously
described [29,30]. After 30 min of MCAO, the filament was
withdrawn and blood flow was restored to basal levels, as assessed
by laser Doppler flowmetry. Wounds were sutured following sur-
gery. The body temperature of experimental mice was monitored
before and after the MCAO surgery using a rectal probe and was
maintained at 37uC using a heating pad and lamp. In preliminary
experiments to verify a consistent stroke procedure, measurements
of blood pressure, blood gases, and pH were also performed.
Sham-operated mice were subjected to the same surgery without
MCAO and used as controls. Mice were allowed to recover for
24 h, 3 d, 7 d, 14 d and 28 d following MCAO.
Brain Tissue Processing
At various reperfusion time points, mice were anesthetized with
isofluorane and sacrificed via decapitation. Fresh brains were
isolated, flash frozen in dry ice and subsequently stored at 280uC.
Ten mm coronal sections were cut using a Leica cryostat (Wetzlar,
Germany) and sections were mounted on 41 mm641 mm stain-
less steel MALDI slides (AB Sciex, Foster City, USA). Mounted
sections were defrosted and dried in-vacu for an hour to prevent
condensation. The plate was then placed in a humidor at ambient
temperature at 80% relative humidity for 1 h. Sections were
sprayed manually with 20 mg of matrix 5-chloro-2-mercaptoben-
zothiazole (CMBT) dissolved in 1 mL solution of chloroform,
ethanol and water (4:4:1 v/v) using an airbrush. MALDI imaging
was done on an Applied Biosystems 4800 MALID TOF/TOF. All
analysis was done in negative ion using linear mode to obtain high
detection sensitivity. The ionization was initiated with a third
harmonic Nd:YAG pulse and 75–150 spectra were then summed
to provide 1 pixel on the image. The pitch of the pixels was
between 50–75 mm. The instrument was controlled via 4000
Series imaging software (Novartis, Mississauga, ON, Canada).
Data analysis and visualization were done using TissueView
(Novartis, Mississauga, ON, Canada).
Quantitation of IMS
Regions of Interest (ROIs) were determined based on Cresyl
violet staining. Mass spectra of several brain areas were measured,
which included the infarcted cerebral cortex (cortex I), the peri-
infarct cortex (the area adjacent to the infarcted cortex, labeled as
Cortex II), the hippocampus and striatum. ROIs were also
assessed for corresponding neuroanatomical regions within the
contralateral hemisphere. Peaks for each species were measured
independently. Total ion chromatographs were generated for each
species and the signal noise was removed by subtracting the
minimum intensity value from each peak. Each species peak was
integrated to calculate the area underneath the peak curve. For
calculation of the peak area, the most intense peak was chosen for
each species, namely [GM1-H]21, [GM2-H]21, [GM3-H]21,
[GD1+K-2H]21 and [GT1b+K-2H]21. The mean peak areas
were calculated for each surgical time point (n = 3) and expressed
as the fold change from ipsilateral to contralateral ROIs. In the
case where the contralateral ROI signal was higher than the
ipsilateral ROI signal, the data was expressed as a fold decrease.
Indirect Immunofluorescence Staining and Confocal
Microscopy
At various reperfusion time points, mice were anesthetized with
isofluorane and perfused transcardially, first with saline followed
by 4% formaldehyde (pH 7.4). Brains were removed, post fixed in
4% formaldehyde (pH 7.4) for 18 h and cryoprotected in 30%
sucrose for 36 h at 4uC. Coronal sections (10 mm thickness) were
cut using a cryostat (Leica Microsystems, Wetzlar, Germany) and
mounted on Superfrost slides (Fisher Scientific, Toronto, ON,
Canada). Sections were rinsed 3 times in 10 mM PBS for 5 min
each. Tissue sections were incubated with the following primary
antibodies: mouse anti-GM1, mouse anti-GD1a (gifts kindly
provided by Dr. Ronald Schnaar from the Johns Hopkins School
of Medicine, Baltimore, USA) or mouse anti-GM3 (AMS Bio-
technology, Lake Forest, CA, USA). Sections were incubated in
primary antibody at a concentration of 1:50 diluted in antibody
buffer containing 10 mM PBS and 1.5% BSA in a humidified
chamber overnight at 4uC. Sections were then washed 3 times
with 10 mM PBS for 10 min. Sections were then incubated with a
Rhodamine Red conjugated goat anti-mouse secondary antibody
(Invitrogen, Carlsbad, CA, USA) at a concentration of 1:600 diluted
in antibody buffer for 1 h at room temperature. Sections were then
washed 3 times in 10 mM PBS for 10 min, mounted with Dako
fluorescent mounting media spiked with 2 mg/ml Hoechst 33258
(Sigma, Toronto, ON, Canada) to counter stain nuclei. Some
sections omitted primary antibody incubation as a negative control.
Confocal imaging was carried out on Olympus Fluoview FV1000
confocal laser scanning microscope (Olympus, Markham, ON,
Canada). Imaging was performed with a 106objective.
Histology
Sections adjacent to those being imaged with MALDI were
stained with Cresyl violet using a protocol as previously described
[31] to observe regions of brain tissue viability loss.
Statistical Analysis
Mean peak areas from individual ganglioside species were
calculated and depicted as fold increase/decrease from ipsilateral
to contralateral ROIs. ANOVA with a Dunnett’s posthoc test was
performed on each ROI comparison and statistical significance
was achieved when p,0.05.
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